COMMUNIQUÉS West-GlobeNewswire

Rexahn Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference

09/11/2017 - 15:00

ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today [...]

Immuron Successfully Completes NASH Phase II Clinical Study Milestone

09/11/2017 - 15:00

MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercialising oral immunotherapeutics for [...]

ADMA Biologics Announces Pricing of Follow-On Offering

09/11/2017 - 14:58

RAMSEY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that develops, [...]

Abeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIA

09/11/2017 - 14:45

Company Opens European Subsidiary in Spain to Support Global Clinical Development Nine subjects at global clinical sites enrolled to date with more than 2,000 days cumulative follow up assessed NEW YORK and CLEVELAND, [...]

Devonian Announces Initiation of Phase IIa Clinical Trial of Thykamine™ in Adult patients with Mild-to-Moderate Atopic Dermatitis

09/11/2017 - 14:45

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD [...]

Devonian annonce l’initiation de l’étude clinique de Phase IIa du Thykamine(MC) chez les patients atteints de Dermatite Atopique légère à modérée

09/11/2017 - 14:45

NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 09 nov. 2017 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) une société [...]

Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights

09/11/2017 - 14:30

SHANGHAI, China and CUPERTINO, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG ) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical company engaged in the development [...]

UroGen Pharma to Present at the Jefferies 2017 London Healthcare Conference

09/11/2017 - 14:30

RA’ANANA, Israel and NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Anthera Pharmaceuticals Announces Completion of Recruitment in the Phase 3 RESULT Clinical Study of Sollpura

09/11/2017 - 14:30

HAYWARD, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced that patient recruitment is now complete for the Phase 3 RESULT clinical study of Sollpura for the [...]

Letter to Shareholders: Acology 10Q Highlights, End of Year Plans

09/11/2017 - 14:30

Tracking Best Sales Year in Company History Well Prepared for Huge Upside for 2018 CORONA, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Acology Inc. From the Desk of Curt Fairbrother Dear Shareholders: As promised before [...]

Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific

09/11/2017 - 14:30

SOLANA BEACH, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the selection of [...]

Novelion Therapeutics Reports Third Quarter 2017 Financial Results and Announces Leadership Change

09/11/2017 - 14:28

Company Reiterates FY 2017 Guidance for Total Net Revenues of $135-$145 million Company Announces Leadership Change and Search for Chief Executive Officer VANCOUVER, British Columbia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- [...]

Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results

09/11/2017 - 14:05

WESTLAKE VILLAGE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today reported the Company’s financial results for the third quarter of 2017. “We are pleased to report the [...]

OmniSeq Receives CAP Accreditation and Publishes Analytical Validation Paper

09/11/2017 - 14:02

BUFFALO, N.Y., Nov. 09, 2017 (GLOBE NEWSWIRE) -- OmniSeq, Inc., a molecular diagnostics subsidiary of Roswell Park Cancer Institute, announced today that it received accreditation by the College of American Pathologists [...]

Decisions of Herantis Pharma Plc's Extraordinary General Meeting of Shareholders

09/11/2017 - 14:01

Decisions of Herantis Pharma Plc's Extraordinary General Meeting of Shareholders Herantis Pharma Plc Company release 9 November 2017 at 3:00 PM An Extraordinary General Meeting of Shareholders of Herantis Pharma Plc was [...]

Jounce Therapeutics to Present at the Stifel 2017 Healthcare Conference

09/11/2017 - 14:00

CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017

09/11/2017 - 14:00

LEXINGTON, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced a workshop [...]

TRACON Pharmaceuticals Presents Updated Data from Phase 1b/2 Study of TRC105 and Votrient® in Patients with Soft Tissue Sarcoma Including Angiosarcoma

09/11/2017 - 14:00

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

Iovance Biotherapeutics Announces New LN-144 Phase 2 Clinical Data from Metastatic Melanoma Trial to be Presented at SITC Meeting

09/11/2017 - 14:00

SAN CARLOS, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]